Last reviewed · How we verify
NCT02150265: SMART
Effectiveness of Six Sessions CBT for Adolescents With Emotional Problems in Community Clinics
NA trial testing SMART manual cognitive behavioral therapy in Generalized Anxiety Disorder in 163 participants. Completed in 1 March 2018.
30 June 2017
Quick facts
| Lead sponsor | University of Tromso |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 163 |
| Start date | 1 January 2013 |
| Primary completion | 30 June 2017 |
| Estimated completion | 1 March 2018 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- SMART manual cognitive behavioral therapy
Conditions studied
- Generalized Anxiety Disorder — all drugs for Generalized Anxiety Disorder →
- Social Phobia — all drugs for Social Phobia →
- Agoraphobia — all drugs for Agoraphobia →
- Depression — all drugs for Depression →
Sponsor
University of Tromso
Who can join
Adults 14 to 18, any sex, with Generalized Anxiety Disorder or Social Phobia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: There is need for more effectiveness studies concerning treatment of emotional symptom problems indicating anxiety and depression in adolescents. SMART is the only treatment manual for combined emotional disorders developed in Norwegian. Purpose: To find the best individualized treatment for adolescents with emotional difficulties by: Finding criteria for the selection of appropriate patients for treatment with cognitive-behavior therapy program SMART in an outpatient population (14-18 years). Finding predictors of completion of treatment program SMART. Examining the effects of treatment with the SMART program at 6 months follow-up. Design: A randomized controlled study in six outpatient clinics in the north of Norway. N= 160 referred adolescents (14-18 years) with score above 6 on the Emotional Problems scale of the Strength and Difficulties Questionnaire (SDQ). Two thirds are treated according to the SMART-manual immediately, while the waiting list control group is treated with SMART after six weeks. Hypothesis: The SMART treatment is an effective treatment for emotional symptom problems. Publication: The results sought published internationally and nationally and will be communicated to clinicians.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
A randomized controlled trial of a six-session cognitive behavioral treatment of emotional disorders in adolescents 14-17 years old in child and adolescent mental health services (CAMHS).
Lorentzen V, Fagermo K, Handegård BH, Skre I, et al · · 2020 · cited 15× · PMID 32171328 · DOI 10.1186/s40359-020-0393-x -
CORE-OM as a routine outcome measure for adolescents with emotional disorders: factor structure and psychometric properties.
Lorentzen V, Handegård BH, Moen CM, Solem K, et al · · 2020 · cited 8× · PMID 32819424 · DOI 10.1186/s40359-020-00459-5 -
Long-term effectiveness and trajectories of change after treatment with SMART, a transdiagnostic CBT for adolescents with emotional problems.
Lorentzen V, Fagermo K, Handegård BH, Neumer SP, et al · · 2022 · cited 2× · PMID 35791020 · DOI 10.1186/s40359-022-00872-y
Verify or expand the search:
- PubMed search for NCT02150265
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Generalized Anxiety Disorder
Currently open trials in the same condition.
- NCT06661460 — Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders · NA · recruiting
- NCT06934525 — Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings · NA · recruiting
- NCT07305701 — Cohort Study on Medical Students' Mental Health · recruiting
- NCT07330648 — Prospective Clinical Trial of Crisugabalin Capsules in the Treatment of Generalized Anxiety Disorder · Phase 2 · recruiting
- NCT07121712 — Navigated cTBS for the Treatment of Generalized Anxiety Disorder · NA · recruiting
Other University of Tromso trials
Trials by the same sponsor.
- NCT07120659 — Vacuum Massage vs Tactile Massage for the Treatment of Chronic Neck Pain · NA · recruiting
- NCT06122441 — RE-inventing Strategies for Healthy Ageing; Recommendations and Tools · NA · active not recruiting
- NCT05794945 — Optimizing Mastitis Identification and Treatment · recruiting
- NCT05398770 — Vitamin D Supplementation Prior to Non-surgical Periodontal Therapy · NA · completed
- NCT05647499 — Evaluating the Back 2 School Program in a Norwegian Setting: A Multicenter Pilot Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02150265 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Tromso
- Last refreshed: 23 May 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02150265.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing